Grupo Catalana Occidente, S.A.

LSE:0NRN Stock Report

Market Cap: €4.3b

Grupo Catalana Occidente Valuation

Is 0NRN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0NRN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0NRN (€36.85) is trading below our estimate of fair value (€91.55)

Significantly Below Fair Value: 0NRN is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0NRN?

Key metric: As 0NRN is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0NRN. This is calculated by dividing 0NRN's market cap by their current earnings.
What is 0NRN's PE Ratio?
PE Ratio7x
Earnings€624.18m
Market Cap€4.35b

Price to Earnings Ratio vs Peers

How does 0NRN's PE Ratio compare to its peers?

The above table shows the PE ratio for 0NRN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average6.9x
AV. Aviva
10.2x4.2%UK£13.0b
HSX Hiscox
6.2x-2.4%UK£3.5b
DLG Direct Line Insurance Group
6.7x8.0%UK£2.0b
BEZ Beazley
4.5x-17.0%UK£4.6b
0NRN Grupo Catalana Occidente
7x-1.4%€4.3b

Price-To-Earnings vs Peers: 0NRN is expensive based on its Price-To-Earnings Ratio (7x) compared to the peer average (6.9x).

Price to Earnings Ratio vs Industry

How does 0NRN's PE Ratio compare vs other companies in the European Insurance Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
0NRN 7.0xIndustry Avg. 11.8xNo. of Companies13PE0816243240+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 0NRN is good value based on its Price-To-Earnings Ratio (7x) compared to the European Insurance industry average (11.8x).

Price to Earnings Ratio vs Fair Ratio

What is 0NRN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0NRN PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio7x
Fair PE Ratio12.1x

Price-To-Earnings vs Fair Ratio: 0NRN is good value based on its Price-To-Earnings Ratio (7x) compared to the estimated Fair Price-To-Earnings Ratio (12.1x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0NRN forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€36.85
€50.61
+37.3%
7.1%€57.00€45.00n/a6
Nov ’25€37.80
€50.28
+33.0%
7.4%€57.00€45.00n/a6
Oct ’25€39.50
€49.77
+26.0%
6.7%€56.00€45.00n/a6
Sep ’25€39.90
€49.78
+24.8%
6.7%€56.00€45.00n/a6
Aug ’25€39.15
€49.78
+27.2%
6.7%€56.00€45.00n/a6
Jul ’25€37.95
€49.29
+29.9%
5.8%€54.00€45.00n/a6
Jun ’25€38.15
€49.28
+29.2%
5.7%€54.00€45.00n/a6
May ’25€36.35
€49.28
+35.6%
5.7%€54.00€45.00n/a6
Apr ’25€35.20
€48.93
+39.0%
6.6%€54.00€45.00n/a5
Mar ’25€33.20
€49.40
+48.8%
6.7%€54.00€45.00n/a4
Feb ’25€33.25
€49.40
+48.6%
6.7%€54.00€45.00n/a4
Jan ’25€30.90
€49.40
+59.9%
6.7%€54.00€45.00n/a4
Dec ’24€32.12
€49.40
+53.8%
6.7%€54.00€45.00n/a4
Nov ’24€30.55
€49.40
+61.7%
6.7%€54.00€45.00€37.804
Oct ’24€30.54
€44.38
+45.3%
14.8%€50.60€32.30€39.505
Sep ’24€30.66
€44.38
+44.7%
14.8%€50.60€32.30€39.905
Aug ’24€30.30
€44.38
+46.5%
14.8%€50.60€32.30€39.155
Jul ’24€28.18
€43.08
+52.9%
13.8%€50.60€32.30€37.955
Jun ’24€29.01
€43.08
+48.5%
13.8%€50.60€32.30€38.155
May ’24€29.29
€42.88
+46.4%
13.9%€50.60€32.30€36.355
Apr ’24€29.05
€45.53
+56.7%
6.6%€50.60€43.00€35.204
Mar ’24€30.65
€45.28
+47.7%
7.2%€50.60€42.00€33.204
Feb ’24€28.52
€43.13
+51.2%
3.9%€46.00€42.00€33.254
Jan ’24€29.73
€43.10
+45.0%
3.9%€46.00€42.00€30.904
Dec ’23€29.70
€43.10
+45.1%
3.9%€46.00€42.00€32.124
Nov ’23€27.60
€42.60
+54.3%
5.1%€46.00€40.00€30.554

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

Hiscox

UK£3.5b

Through its subsidiaries, provides insurance and reinsurance services in the United Kingdom, Europe, the United States, and internationally.

HSX

UK£10.36

7D

-2.3%

1Y

3.1%

Münchener Rückversicherungs-Gesellschaft in München

€62.6b

Engages in the insurance and reinsurance businesses worldwide.

0KFE

€472.30

7D

-1.5%

1Y

24.0%

Powszechny Zaklad Ubezpieczen

zł35.5b

Provides life and non-life insurance products and services in Poland, the Baltic States, and Ukraine.

0MYY

zł41.01

7D

-0.3%

1Y

n/a